Onco-Innovations Limited
Onco-Innovations Limited
Indice CSE:
Devise:
Onco-Innovations Limited is a Canadian biotech company dedicated to developing and commercializing treatments for various types of cancer. The company holds an exclusive license for the PNKP Inhibitor Technology and an exclusive sublicense for the Drug Delivery Technology. Together, these technologies have shown the potential to significantly enhance treatment outcomes, particularly for colorectal cancer.
Onco-Innovations Limited (ONCO)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Information d'entreprise
Addresse
1309-7th Street SW
Vancouver, BC V6C 2B5
CanadaTéléphone
(236) 521-0626Courriel
nl@amalficorp.caURL
https://www.oncoinnovations.comDate d’inscription à la cote
Mardi, novembre 26, 2024
Agent de transfert
Endeavor Trust CorporationSEDAR Information
Information d'entreprise
Addresse
1309-7th Street SW
Vancouver, BC V6C 2B5
CanadaTéléphone
(236) 521-0626Courriel
nl@amalficorp.caURL
https://www.oncoinnovations.comDate d’inscription à la cote
Mardi, novembre 26, 2024
Agent de transfert
Endeavor Trust CorporationCapitalisation
Capitalisation:
50180810Réservé à l'émission:
4979083Company Officers
Thomas O'Shaughnessy, CEO
Nico Mah, CFO and Corporate Secretary
Communiqués de presse
Dépôts CSE
